Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) rose sharply in today's pre-market trading. Lundbeck agreed to acquire Longboard Pharmaceuticals in a transaction valued at approximately $2.6 ...
Initiated Single-Ascending Dose (SAD) Phase 1 clinical study evaluating LP659 LA JOLLA, Calif.--(BUSINESS WIRE)-- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results